title: Treatment response of cutaneous mantle cell lymphoma to ibrutinib and radiotherapy.
authors.affiliation: Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Silvia E
authors.initials: SE
authors.lastname: Mancebo
authors.affiliation: Department of Dermatology, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY.
authors.forename: Jeffrey R
authors.initials: JR
authors.lastname: Smith
authors.affiliation: Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Andrew M
authors.initials: AM
authors.lastname: Intlekofer
authors.affiliation: Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Andrew D
authors.initials: AD
authors.lastname: Zelenetz
authors.affiliation: Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Dermatology, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY. Electronic address: myskowsp@mskcc.org.
authors.forename: Patricia L
authors.initials: PL
authors.lastname: Myskowski
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017809:Fatal Outcome; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy* / Q000532:radiotherapy*; D008297:Male; D010880:Piperidines; D011720:Pyrazoles / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D019233:Retreatment; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*
chemical_list: D000970:Antineoplastic Agents; D010880:Piperidines; D011720:Pyrazoles; D011743:Pyrimidines; C551803:ibrutinib; D000225:Adenine
keywords: Adjuvant radiotherapy; Btk inhibitor; Cutaneous MCL; Cutaneous lymphoma; MCL relapse